Dietary therapy with bovine colostrum to improve nutrition and gut health in paediatric Crohn’s disease; a feasibility study

Alder Hey Children's NHS Foundation Trust0 个研究点目标入组 23 人开始时间: 2019年7月8日最近更新: 2023年1月9日

试验速览

2022 Results article in https://doi.org/10.3390/nu14214598 (added 02/12/2022)

•1. Aged 8 years and above
•2. CD in clinical remission or mild/moderate disease severity (weighted pCD Activity Index [wPCDAI] =57.5)
•3. Stable clinical condition defined as either receiving no treatment or maintenance therapy that has been unchanged for at least the last 2 months with no intention to change therapy at the time of recruitment
•4. Willing for clinical information to be used for the purposes of the trial
•5. Willing to partake in the study procedures
•6. Able to complete the daily diary in English

•1. Severe CD (wPCDAI >57.5)
•2. Intolerance of dairy products
•3. Receiving dietary therapy for the management of Crohn’s disease (e.g. Modulen IBD)
•4. Already taking BC regularly
•5. Established diagnosis of a significant gut disorder other than CD (e.g. short bowel syndrome)
•6. Failure to obtain informed consent from the patient and/or parent/guardian

发起方